ArticleImmunotherapy2025
Proton pump inhibitors reduce nivolumab efficacy in unresectable advanced or recurrent gastric cancer.
Masahito Shibano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it